Nature Portfolio aims to enhance the reproducibility of published research through structured reporting guidelines. This section outlines specific requirements for statistical analyses, software and code availability, data availability, and ethical considerations for studies involving human participants or biological materials. - **Sample Size and Measurement**: Provide the exact sample size and whether measurements were from distinct samples or repeated on the same sample. - **Statistical Tests**: State the type of statistical test used (one- or two-sided) and describe complex techniques in the Methods section. - **Covariates and Assumptions**: Describe all covariates tested and any assumptions or corrections made. - **Statistical Parameters**: Include central tendency, variation, and uncertainty estimates. - **Null Hypothesis Testing**: Provide test statistics, confidence intervals, effect sizes, degrees of freedom, and P values. - **Bayesian Analysis**: Mention prior choices and Markov chain Monte Carlo settings. - **Hierarchical Designs**: Identify the appropriate level for tests and report outcomes. - **Effect Sizes**: Calculate and report effect sizes (e.g., Cohen’s d, Pearson’s r). - **Code Availability**: Authors must provide information about the availability of computer code. - **Data Availability Statement**: Include access codes, unique identifiers, or web links for publicly available datasets, and describe any restrictions. - **Clinical Data**: Ensure compliance with policies for clinical datasets or third-party data. - **Human Participants**: Provide full details of study protocol approval. - **Field Work**: Disclose whether the study involved field work. - **Materials & Experimental Systems**: Indicate the relevance of materials, systems, and methods used in the study. - **Plants**: Report on seed stocks, novel plant genotypes, and their sources, methods of production, and authentication procedures. - **Seed Stocks**: Source, catalogue number, collection details, and authentication procedures. - **Novel Plant Genotypes**: Methods of production, transformation details, editing methods, and assessment of mutations and secondary effects.Nature Portfolio aims to enhance the reproducibility of published research through structured reporting guidelines. This section outlines specific requirements for statistical analyses, software and code availability, data availability, and ethical considerations for studies involving human participants or biological materials. - **Sample Size and Measurement**: Provide the exact sample size and whether measurements were from distinct samples or repeated on the same sample. - **Statistical Tests**: State the type of statistical test used (one- or two-sided) and describe complex techniques in the Methods section. - **Covariates and Assumptions**: Describe all covariates tested and any assumptions or corrections made. - **Statistical Parameters**: Include central tendency, variation, and uncertainty estimates. - **Null Hypothesis Testing**: Provide test statistics, confidence intervals, effect sizes, degrees of freedom, and P values. - **Bayesian Analysis**: Mention prior choices and Markov chain Monte Carlo settings. - **Hierarchical Designs**: Identify the appropriate level for tests and report outcomes. - **Effect Sizes**: Calculate and report effect sizes (e.g., Cohen’s d, Pearson’s r). - **Code Availability**: Authors must provide information about the availability of computer code. - **Data Availability Statement**: Include access codes, unique identifiers, or web links for publicly available datasets, and describe any restrictions. - **Clinical Data**: Ensure compliance with policies for clinical datasets or third-party data. - **Human Participants**: Provide full details of study protocol approval. - **Field Work**: Disclose whether the study involved field work. - **Materials & Experimental Systems**: Indicate the relevance of materials, systems, and methods used in the study. - **Plants**: Report on seed stocks, novel plant genotypes, and their sources, methods of production, and authentication procedures. - **Seed Stocks**: Source, catalogue number, collection details, and authentication procedures. - **Novel Plant Genotypes**: Methods of production, transformation details, editing methods, and assessment of mutations and secondary effects.